CompletedPhase 2NCT01998633
Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)
Studying Chronic granulomatous disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical College of Wisconsin
- Principal Investigator
- Mary Horowitz, MD, MSCenter for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
- Intervention
- Hematopoietic Stem Cell Transplant(biological)
- Enrollment
- 47 enrolled
- Eligibility
- 45 years · All sexes
- Timeline
- 2013 – 2016
Study locations (22)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Johns Hopkins, Baltimore, Maryland, United States
- Dana Farber Cancer Institute/Children's Hospital of Boston, Boston, Massachusetts, United States
- University of Michigan Medical Center, Ann Arbor, Michigan, United States
- Washington University/St. Louis Children's Hospital, St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
- University of Rochester Medical Center, Rochester, New York, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Oregon Health and Science University, Portland, Oregon, United States
- Children's Medical Center of Dallas, Dallas, Texas, United States
- +7 more locations on ClinicalTrials.gov
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · Blood and Marrow Transplant Clinical Trials Network · National Cancer Institute (NCI) · National Marrow Donor Program
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01998633 on ClinicalTrials.govOther trials for Chronic granulomatous disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07284641Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)Paul Szabolcs
- ENROLLING BY INVITATIONPHASE1NCT07113743Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE1, PHASE2NCT06876363Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous DiseaseEnsoma
- RECRUITINGNCT06605378Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous DiseaseEnsoma
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT06559176A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )Prime Medicine, Inc.
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT06253507pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)National Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE1NCT06325709Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT05600907Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)National Institute of Allergy and Infectious Diseases (NIAID)